The Placement of Aortic Transcatheter Valves ( PARTNER ) trial reported a reduced rate of mortality in patients with previous coronary bypass grafting ( CABG ) operation who received surgical aortic valve replacement ( SAVR ) in comparison with transcatheter aortic valve replacement ( TAVR ) .